Since its description, irisin has been associated with several metabolic diseases, i.e., type 2 diabetes mellitus, obesity, cardiovascular disease, polycystic ovary syndrome and metabolic dysfunction associated steatotic liver disease. The gene discussed is FNDC5; the disease is type 2 diabetes mellitus.